Please login to the form below

Not currently logged in
Email:
Password:

gastroenterology

This page shows the latest gastroenterology news and features for those working in and with pharma, biotech and healthcare.

Takeda to sell Japan consumer health unit for $2.3bn

Takeda to sell Japan consumer health unit for $2.3bn

This includes gastroenterology, rare disease, plasma-derived therapies, oncology and neuroscience, five therapy areas which the Japanese pharma company said are core to its global long-term growth.

Latest news

More from news
Approximately 3 fully matching, plus 66 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

  • emotive bolsters client services team emotive bolsters client services team

    During her six years at Chameleon, she was responsible for medical communications acitivites in various therapy areas including diabetes, cardiology, immunology, gastroenterology and rare diseases.

  • Clark Health Communications expands team Clark Health Communications expands team

    director in a role that will see her lead teams responsible for driving the delivery of CHC’s gastroenterology, women’s health, depression and anticoagulants business. ... Campbell will support and assist the team across its women’s health,

  • Sam Agus takes up new role at Hansa Medical Sam Agus takes up new role at Hansa Medical

    With experience in medical strategy, multidisciplinary team leadership, medical marketing and clinical trial design, Agus’s therapy area expertise includes neurology, psychiatry, gastroenterology, women’s health and rare diseases.

  • Virgo Health Education expands team Virgo Health Education expands team

    Prior to this, he served as a medial doctor at Chelsea &Westminster hospital, working in a number of specialties including acute medicine, gastroenterology and colorectal surgery.

  • Dr Andrew Mulberg moves from FDA to Amicus Therapeutics Dr Andrew Mulberg moves from FDA to Amicus Therapeutics

    He joins Amicus from the US Food and Drug Administration ( FDA), where he most recently served as deputy director of the division of gastroenterology and inborn errors products. ... Dr Mulberg is a pediatric gastroenterologist, and was attending

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • IBD Registry wins Communiqué award for COVID-19 tool

    The organisation worked closely with partners at the British Society of Gastroenterology and Crohn’s and Colitis UK, with vital support from sponsors including Amgen, Galapagos, Gilead and Tillotts UK.

  • Three strategies for managing loss of exclusivity successfully

    its overall Gastroenterology franchise – by nearly 9% from 2001 to 2002.

  • Three is the magic number Three is the magic number

    Since joining Aurora, she has expanded her pharma portfolio, working in therapeutic areas including gastroenterology and rare diseases on awareness, education, and patient advocacy. ... Since joining Aurora, she has been working on various global

  • It's all about the cake/lettuce balance

    moderation”. To raise awareness of WDHD, each year the World Gastroenterology Organisation (WGO), in collaboration with the WGO Foundation (WGOF), focus on a particular digestive disease in order to increase general ... References:. “Obesity in the

  • NHS medicines optimisation milestone

    Pharma also needs to think about the NHS’s move into integrated health and social care systems, which is particularly relevant to gastroenterology and musculoskeletal (MSK) disorders.

More from PMHub
Approximately 0 fully matching, plus 22 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...